JP2022535064A5 - - Google Patents
Info
- Publication number
- JP2022535064A5 JP2022535064A5 JP2021571699A JP2021571699A JP2022535064A5 JP 2022535064 A5 JP2022535064 A5 JP 2022535064A5 JP 2021571699 A JP2021571699 A JP 2021571699A JP 2021571699 A JP2021571699 A JP 2021571699A JP 2022535064 A5 JP2022535064 A5 JP 2022535064A5
- Authority
- JP
- Japan
- Prior art keywords
- polysaccharide
- protein conjugate
- streptococcus pneumoniae
- serotypes
- derived
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201962857534P | 2019-06-05 | 2019-06-05 | |
| US62/857,534 | 2019-06-05 | ||
| PCT/US2020/035511 WO2020247301A1 (en) | 2019-06-05 | 2020-06-01 | Methods of treating patients with an immunogenic composition that protects against s. pneumoniae serotype 29 |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2022535064A JP2022535064A (ja) | 2022-08-04 |
| JP2022535064A5 true JP2022535064A5 (enExample) | 2023-06-20 |
Family
ID=73653320
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2021571699A Pending JP2022535064A (ja) | 2019-06-05 | 2020-06-01 | 肺炎レンサ球菌血清型２９から保護する免疫原性組成物で患者を治療する方法 |
Country Status (10)
| Country | Link |
|---|---|
| US (1) | US20220218812A1 (enExample) |
| EP (1) | EP3980050A4 (enExample) |
| JP (1) | JP2022535064A (enExample) |
| KR (1) | KR20220016964A (enExample) |
| CN (1) | CN114025784A (enExample) |
| AU (1) | AU2020289048A1 (enExample) |
| BR (1) | BR112021024491A8 (enExample) |
| CA (1) | CA3142697A1 (enExample) |
| MX (1) | MX2021014948A (enExample) |
| WO (1) | WO2020247301A1 (enExample) |
Families Citing this family (9)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP4656208A3 (en) | 2017-01-31 | 2026-03-04 | Merck Sharp & Dohme LLC | Methods for making polysaccharide-protein conjugates |
| JP7680185B2 (ja) | 2017-02-24 | 2025-05-20 | メルク・シャープ・アンド・ドーム・エルエルシー | 肺炎連鎖球菌多糖－タンパク質コンジュゲートの免疫原性の増強 |
| MX394768B (es) | 2017-09-07 | 2025-03-21 | Merck Sharp & Dohme Llc | Polisacaridos neumococicos y su uso en conjugados de polisacarido inmunogenico con proteina. |
| MX394767B (es) | 2017-09-07 | 2025-03-24 | Merck Sharp & Dohme Llc | Polisacaridos neumococicos y su uso en conjugados de polisacarido inmunogenico con proteina transportadora. |
| ES3058336T3 (es) | 2017-12-06 | 2026-03-10 | Merck Sharp & Dohme Llc | Composiciones que comprenden conjugados polisacárido-proteína de Streptococcus pneumoniae y métodos de uso de los mismos |
| EP3787673A4 (en) | 2018-04-30 | 2022-04-27 | Merck Sharp & Dohme Corp. | Methods for producing streptococcus pneumoniae capsular polysaccharide carrier protein conjugates |
| EP3788143B1 (en) | 2018-04-30 | 2023-06-28 | Merck Sharp & Dohme LLC | Methods for providing a homogenous solution of lyophilized mutant diptheria toxin in dimethylsulfoxide |
| US12144855B2 (en) | 2018-04-30 | 2024-11-19 | Merck Sharp & Dohme Llc | Methods for producing streptococcus pneumoniae capsular polysaccharide carrier protein conjugates from lyospheres |
| CR20210333A (es) | 2018-12-19 | 2021-08-18 | Merck Sharp & Dohme | Composiciones que comprenden conjugados de polisacárido de streptococcus pneumoniae con proteína y sus métodos de uso |
Family Cites Families (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP2311976A1 (en) * | 2009-10-19 | 2011-04-20 | Azienda Ospedaliero-Universitaria Meyer | Method for Streptococcus Pneumoniae diagnosis and serotyping |
| TW201136603A (en) * | 2010-02-09 | 2011-11-01 | Merck Sharp & Amp Dohme Corp | 15-valent pneumococcal polysaccharide-protein conjugate vaccine composition |
| EP3436061A4 (en) * | 2016-03-31 | 2019-12-04 | Liffey Biotech Limited | Saccharide-polypeptide-conjugate compositions and methods of use thereof |
| NZ752348A (en) * | 2016-09-30 | 2022-11-25 | Biological E Ltd | Multivalent pneumococcal vaccine compositions comprising polysaccharide-protein conjugates |
| CN110366428B (zh) * | 2016-12-30 | 2024-05-17 | Vaxcyte公司 | 具有非天然氨基酸的多肽-抗原缀合物 |
-
2020
- 2020-06-01 BR BR112021024491A patent/BR112021024491A8/pt unknown
- 2020-06-01 KR KR1020227000140A patent/KR20220016964A/ko not_active Withdrawn
- 2020-06-01 AU AU2020289048A patent/AU2020289048A1/en not_active Abandoned
- 2020-06-01 EP EP20819293.0A patent/EP3980050A4/en not_active Withdrawn
- 2020-06-01 JP JP2021571699A patent/JP2022535064A/ja active Pending
- 2020-06-01 CA CA3142697A patent/CA3142697A1/en active Pending
- 2020-06-01 MX MX2021014948A patent/MX2021014948A/es unknown
- 2020-06-01 CN CN202080049226.4A patent/CN114025784A/zh active Pending
- 2020-06-01 WO PCT/US2020/035511 patent/WO2020247301A1/en not_active Ceased
- 2020-06-01 US US17/614,876 patent/US20220218812A1/en not_active Abandoned
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2022535064A5 (enExample) | ||
| FI3720483T3 (fi) | Streptococcus pneumoniaen polysakkaridi-proteiinikonjugaatteja käsittäviä koostumuksia ja niiden käyttömenetelmiä | |
| PH12022550110A1 (en) | Multivalent pneumococcal polysaccharide-protein conjugate compositions and methods of using the same | |
| JP2019526621A5 (enExample) | ||
| IL276229B2 (en) | Multivalent pneumococcal polysaccharide-protein conjugate composition | |
| JP2021505589A5 (enExample) | ||
| PH12019500240A1 (en) | Multivalent pneumococcal polysaccharide-protein conjugate composition | |
| JP2021512870A5 (enExample) | ||
| PH12020551149A1 (en) | Multivalent pneumococcal polysaccharide-protein conjugate composition | |
| JP2019526620A5 (enExample) | ||
| SA519401028B1 (ar) | تركيب متقارن من عديد السكاريد للمكورة الرئوية متعددة التكافؤ - وبروتين | |
| JP2020533437A5 (enExample) | ||
| JP2022513562A5 (enExample) | ||
| HRP20221438T1 (hr) | Postupak glikokonjugiranja | |
| HRP20161681T1 (hr) | Cjepivo protiv bakterije streptococcus pneumoniae | |
| PE20161095A1 (es) | Composiciones inmunogenicas que comprenden antigenos de sacaridos capsulares conjugados y uso de los mismos | |
| AR040922A1 (es) | Composicion inmunogenica multivalente, uso de la misma para la fabricacion de un medicamento y procedimiento para preparar dicha composicion inmunogenica multivalente | |
| RU2021138121A (ru) | Способы лечения пациентов иммуногенной композицией, защищающей от серотипа 29 s. pneumoniae | |
| TW202617178A (zh) | 多價肺炎球菌多醣-蛋白質共軛物組成物及使用其之方法 | |
| EA202091440A1 (ru) | Поливалентная противопневмококковая полисахаридно-белковая конъюгированная композиция | |
| AR122291A1 (es) | Composiciones conjugadas neumocócicas multivalentes polisacárido - proteína y métodos para usar las mismas | |
| Choi et al. | Serotypes and antimicrobial susceptibility of Streptococcus pneumoniae | |
| Melo-Cristino et al. | 774; Non-invasive pneumococcal pneumonia has its own and distinct serotype distribution in Portugal | |
| NZ770014A (en) | Streptococcus pneumoniae capsular polysaccharides and immunogenic conjugate thereof | |
| NZ770014B2 (en) | Streptococcus pneumoniae capsular polysaccharides and immunogenic conjugate thereof |